Reduced mRNA Expression of PTGDS in Peripheral Blood Mononuclear Cells of Rapid-Cycling Bipolar Disorder Patients Compared with Healthy Control Subjects

White matter hyperintensities and cognitive performance in adult patients with bipolar I, bipolar II, and major depressive disorders

(2013) T. Kieseppä et al.   EUROPEAN PSYCHIATRY

Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Depressive Patients Increase During Lithium Augmentation of Antidepressants

(2013) Roland Ricken et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis

(2013) Klaus Munkholm et al.   JOURNAL OF PSYCHIATRIC RESEARCH

State-related alterations of gene expression in bipolar disorder: a systematic review

(2012) Klaus Munkholm et al.   BIPOLAR DISORDERS

Differential expression of prostaglandin D2 synthase (PTGDS) in patients with attention deficit–hyperactivity disorder and bipolar disorder

(2012) Juan Jesús Marín-Méndez et al.   JOURNAL OF AFFECTIVE DISORDERS

Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability

(2012) Hiren R. Modi et al.   JOURNAL OF NEUROCHEMISTRY

The ALDH2 and 5-HT2A genes interacted in bipolar-I but not bipolar-II disorder

(2012) Sheng-Yu Lee et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Correction for Multiple Testing

(2011) David L. Streiner et al.   CHEST

Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E2 concentration in rat brain

(2011) Yewon Cheon et al.   JOURNAL OF NEUROCHEMISTRY

Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder

(2011) D T Chen et al.   MOLECULAR PSYCHIATRY

Survey of the effect of genetic variations on gene expression in human prefrontal cortex and its application to genetics of psychiatric disorders

(2011) Kazuya Iwamoto et al.   NEUROSCIENCE RESEARCH

Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

(2010) Hayley B. Clay et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE

A systemic toxicity index developed to assess peripheral changes in mood episodes

(2010) F Kapczinski et al.   MOLECULAR PSYCHIATRY

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

(2010) Michael Maes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?

(2009) Richard P. Bazinet   BIOCHEMICAL SOCIETY TRANSACTIONS

Bipolar disorder and mechanisms of action of mood stabilizers

(2009) Stanley I. Rapoport et al.   BRAIN RESEARCH REVIEWS

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

(2009) Shahin Akhondzadeh et al.   DEPRESSION AND ANXIETY

Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder

(2009) Benjamin I. Goldstein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

(2009) H-W Kim et al.   MOLECULAR PSYCHIATRY

Aspirin, arachidonic acid and the regulation of mood

(2009) Richard P. Bazinet   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Neuroprogression: pathways to progressive brain changes in bipolar disorder

(2008) Michael Berk   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Unknown

(2008) Martin Begemann et al.   MOLECULAR MEDICINE

Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to ‘switching’ in bipolar disorder?

(2008) H-J Lee et al.   MOLECULAR PSYCHIATRY

Identifying blood biomarkers for mood disorders using convergent functional genomics

(2008) H Le-Niculescu et al.   MOLECULAR PSYCHIATRY